Cargando…

A protective mutation against Alzheimer disease?

To date, nearly 35.6 million people world wide live with dementia, and the situation is going to get worse by 2050 with 115.4 million cases.(1) In the western world, the prevalence for dementia in people over the age of 60 is greater than 5% and two thirds are due to Alzheimer disease,(2)(-)(5) the...

Descripción completa

Detalles Bibliográficos
Autores principales: Proft, Juliane, Weiss, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460828/
https://www.ncbi.nlm.nih.gov/pubmed/23060947
http://dx.doi.org/10.4161/cib.21799
_version_ 1782244991957991424
author Proft, Juliane
Weiss, Norbert
author_facet Proft, Juliane
Weiss, Norbert
author_sort Proft, Juliane
collection PubMed
description To date, nearly 35.6 million people world wide live with dementia, and the situation is going to get worse by 2050 with 115.4 million cases.(1) In the western world, the prevalence for dementia in people over the age of 60 is greater than 5% and two thirds are due to Alzheimer disease,(2)(-)(5) the most common form of dementias.   Alzheimer disease (AD), first described as “presenile dementia” by the German psychiatrist and neuropathologist Alois Alzheimer in 1906,(6) is a devastating disease characterized by progressive cognitive deterioration, as well as impairments in behavior, language, and visuospatial skills.(7) Furthermore, Alzheimer discovered the presence of intraneuronal tangles and extracellular amyloid plaques in the diseased-damaged brain, the hallmarks of Alzheimer disease.
format Online
Article
Text
id pubmed-3460828
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-34608282012-10-11 A protective mutation against Alzheimer disease? Proft, Juliane Weiss, Norbert Commun Integr Biol Commentary To date, nearly 35.6 million people world wide live with dementia, and the situation is going to get worse by 2050 with 115.4 million cases.(1) In the western world, the prevalence for dementia in people over the age of 60 is greater than 5% and two thirds are due to Alzheimer disease,(2)(-)(5) the most common form of dementias.   Alzheimer disease (AD), first described as “presenile dementia” by the German psychiatrist and neuropathologist Alois Alzheimer in 1906,(6) is a devastating disease characterized by progressive cognitive deterioration, as well as impairments in behavior, language, and visuospatial skills.(7) Furthermore, Alzheimer discovered the presence of intraneuronal tangles and extracellular amyloid plaques in the diseased-damaged brain, the hallmarks of Alzheimer disease. Landes Bioscience 2012-07-01 /pmc/articles/PMC3460828/ /pubmed/23060947 http://dx.doi.org/10.4161/cib.21799 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Commentary
Proft, Juliane
Weiss, Norbert
A protective mutation against Alzheimer disease?
title A protective mutation against Alzheimer disease?
title_full A protective mutation against Alzheimer disease?
title_fullStr A protective mutation against Alzheimer disease?
title_full_unstemmed A protective mutation against Alzheimer disease?
title_short A protective mutation against Alzheimer disease?
title_sort protective mutation against alzheimer disease?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460828/
https://www.ncbi.nlm.nih.gov/pubmed/23060947
http://dx.doi.org/10.4161/cib.21799
work_keys_str_mv AT proftjuliane aprotectivemutationagainstalzheimerdisease
AT weissnorbert aprotectivemutationagainstalzheimerdisease
AT proftjuliane protectivemutationagainstalzheimerdisease
AT weissnorbert protectivemutationagainstalzheimerdisease